title: Rifampicin-macrolide synergy against Legionella pneumophila serogroup 1 in human macrophages using a quantitative real-time PCR assay.
authors.forename: Ghislaine
authors.initials: G
authors.lastname: Descours
authors.forename: Christophe
authors.initials: C
authors.lastname: Ginevra
authors.forename: Florence
authors.initials: F
authors.lastname: Ader
authors.forename: Françoise
authors.initials: F
authors.lastname: Forey
authors.forename: Gerard
authors.initials: G
authors.lastname: Lina
authors.forename: Jerome
authors.initials: J
authors.lastname: Etienne
authors.forename: Sophie
authors.initials: S
authors.lastname: Jarraud
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D058491:Bacterial Load / Q000379:methods*; D002460:Cell Line; D004357:Drug Synergism; D006801:Humans; D016952:Legionella pneumophila / Q000187:drug effects*; D018942:Macrolides / Q000494:pharmacology*; D008264:Macrophages / Q000382:microbiology*; D008826:Microbial Sensitivity Tests; D050296:Microbial Viability / Q000187:drug effects; D016133:Polymerase Chain Reaction / Q000379:methods; D012293:Rifampin / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides; D012293:Rifampin